Cholesterol-and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe
| dc.contributor.author | Achelrod, D | en_US |
| dc.contributor.author | Gray, A | en_US |
| dc.contributor.author | Preiss, D | en_US |
| dc.contributor.author | Mihaylova, B | en_US |
| dc.date.accessioned | 2018-11-14T09:56:56Z | |
| dc.date.issued | 2017-03 | en_US |
| dc.date.submitted | 2018-05-31T11:26:57.150Z | |
| dc.identifier.issn | 2047-4873 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/50384 | |
| dc.description.sponsorship | The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: DA received funding by a university research grant, awarded by the Hamburg Center for Health Economics, University of Hamburg, Germany. This paper uses data from SHARE Wave 1-5, as of 31 March 2015. The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, N° 211909, SHARE-LEAP, N° 227822 and SHARE M4, N° 261982). Additional funding from the US National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064) and the German Ministry of Education and Research as well as from various national sources is gratefully acknowledged (www.share-project.org). | en_US |
| dc.format.extent | 426 - 436 | en_US |
| dc.relation.ispartof | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | en_US |
| dc.rights | Copyright © 2016 The European Society of Cardiology. This is the author accepted manuscript following peer review version of the article. The final version is available online from SAGE at: 10.1177/2047487316676906 | |
| dc.subject | Cardiovascular disease | en_US |
| dc.subject | cholesterol-lowering drug therapy | en_US |
| dc.subject | blood pressure drug therapy | en_US |
| dc.subject | medication compliance | en_US |
| dc.title | Cholesterol-and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe | en_US |
| dc.type | Article | |
| dc.rights.holder | © The European Society of Cardiology 2016 | |
| dc.identifier.doi | 10.1177/2047487316676906 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397434200013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 4 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 24 | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
